`
`FOR THE DISTRICT OF DELAWARE
`
`GENENTECH, INC. and CITY OF HOPE,
`
`Plaintiffs,
`
`Case No. 18-0924-CFC
`
`V.
`
`AMGEN INC”
`
`
`
`Defendant.
`
`PUBLIC VERSION
`PUBLIC VERSION
`
`DECLARATION OF ROBERT JACOBSON
`
`IN SUPPORT OF AMGEN’S OPPOSITION TO GENENTECH’S EMERGENCY
`
`MOTIONS FOR A TEMPORARY RESTRAINING ORDER AND A PRELIMINARY
`
`INJUNCTION
`
`
`
`1.
`
`My name is Robert Jacobson.
`
`i am the Executive Director of US.
`
`Value and Access for Biosirnilars at Aingen.
`
`1 have held this role since July 20‘ 7,
`
`and I have been employed by Amgen since March 2001 .
`
`a
`‘
`in my Current role (.15 die Exec-mire lilirec’ror ol‘UrS. ‘v’nluc and Access
`
`2’.
`
`{Ul’
`
`,fiiObllllllaAbfi
`
`A U‘Ukleu [Belugali 3:: dhl,;"-’lll€.b
`
`Jii
`
`li‘lb
`
`{cu-.33.,
`
`l
`(Liaill'éil Ua' QUX‘jlgfi
`
`con'iirkrcliirg,,, and patient support {or .firrngen’s hiosimilar programs,
`
`i also oversees
`
`Amgen’s US. policy work related to these areas of value and access for biosimilars.
`
`3.
`
`Kanjinti® is Amgen’s trastuzuma‘o biosimilar.—
`
`
`
`
`Amgen received FDA approval to market Kanjinti® on June 13, 2019.
`
`4.
`
`
`
`
`
`
`
`I declare under penalty ofperjury that the foregoing is true and correct to the
`
`best ofmy personal knowledge.
`
`“a
`
`A
`
`\
`
`__“_ H ~
`
`\
`
`A
`
`/
`,
`
`l ’ h
`\
`-,
`J
`
`l
`\
`, new,» e ‘__
`_
`,,.——‘l...._
`-W
`
`w.
`147-;va
`
`‘
`,f I
`.- .. .fi.‘
`J V
`
`-
`
`_ __
`
`1
`.
`“f
`
`.
`
`, 19'
`
`”
`
`:7
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I HEREBY CERTIFY that on July 15, 2019, a true and correct copy of the foregoing
`
`DECLARATION OF ROBERT JACOBSON IN SUPPORT OF AMGEN’S COMBINED
`
`OPPOSITION TO GENENTECH’S EMERGENCY MOTIONS FOR A TEMPORARY
`
`RESTRAINING ORDER AND A PRELIMINARY INJUNCTION
`
` was served on the following by electronic mail:
`
`Michael P. Kelly
`Daniel M. Silver
`Alexandra Joyce
`MCCARTER & ENGLISH, LLP
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, DE 19801
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /s/ Neal C. Belgam
`Neal C. Belgam (No. 2721)
`
`
`
`
`
`
`
`
`
`
`
`
`